We spoke with leaders and experts in the Clinical Research community about their predictions for 2024. There are many anticipated developments in AI and machine learning, particularly in how it can support clinical trials. “In 2024, the pivotal factor for clinical trial success lies in the adept utilization of AI,” says Niven R. Narain of BPGBio. “After a year of several highly anticipated AI-designed drug candidates failing in clinical trials, this next year represents an opportunity for companies who have quietly continued to focus on biology, progressing in clinical trials with proprietary AI platforms and algorithms to step into the light.”